Accuracy of GFR estimating equations based on creatinine, cystatin C or both in routine care

Author:

Fu Edouard L123ORCID,Levey Andrew S4,Coresh Josef5,Grams Morgan E6,Faucon Anne-Laure27ORCID,Elinder Carl-Gustaf8,Dekker Friedo W3,Delanaye Pierre910,Inker Lesley A4,Carrero Juan-Jesus211ORCID

Affiliation:

1. Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women's Hospital and Harvard Medical School , Boston, MA , USA

2. Department of Medical Epidemiology and Biostatistics, Karolinska Institute , Stockholm , Sweden

3. Department of Clinical Epidemiology, Leiden University Medical Center , Leiden , The Netherlands

4. Division of Nephrology, Department of Internal Medicine, Tufts Medical Center , Boston, MA , USA

5. Department of Epidemiology, Johns Hopkins University Bloomberg School of Public Health , Baltimore, MD , USA

6. Division of Precision Medicine, Department of Medicine, New York University Grossman School of Medicine , New York, NY , USA

7. INSERM UMR 1018, Department of Clinical Epidemiology, Paris-Saclay University , Paris , France

8. Division of Renal Medicine, Department of Clinical Intervention, and Technology, Karolinska University Hospital and Karolinska Institute , Stockholm , Sweden

9. Department of Nephrology-Dialysis-Transplantation, University of Liège , CHU Sart Tilman, Liège , Belgium

10. Department of Nephrology-Dialysis-Apheresis, Hôpital Universitaire Carémeau , Nîmes , France

11. Division of Nephrology, Department of Clinical Sciences, Danderyd Hospital, Karolinska Institutet , Stockholm , Sweden

Abstract

ABSTRACT Background New equations to estimate glomerular filtration rate based on creatinine (eGFRcr), cystatin C (eGFRcys) or both (eGFRcr-cys) have been developed by the Chronic Kidney Disease Epidemiology Collaboration (CKD-EPI) and the European Kidney Function Consortium (EKFC). There is a need to evaluate the performance of these equations in diverse European settings to inform implementation decisions, especially among people with key comorbid conditions. Methods We performed a cross-sectional study including 6174 adults referred for single-point plasma clearance of iohexol in Stockholm, Sweden, with 9579 concurrent measurements of creatinine and cystatin C. We assessed the performance of the CKD-EPI 2009/2012/2021, EKFC 2021/2023, revised Lund-Malmö (RLM) 2011 and Caucasian, Asian, Pediatric and Adult (CAPA) 2014 equations against measured GFR (mGFR). Results Mean age was 56 years, median mGFR was 62 mL/min/1.73 m2 and 40% were female. Comorbid conditions were common: cardiovascular disease (30%), liver disease (28%), diabetes (26%) and cancer (26%). All eGFRcr-cys equations had small bias and P30 (the percentage of estimated values within 30% of mGFR) close to 90%, and performed better than eGFRcr or eGFRcys equations. Among eGFRcr equations, CKD-EPI 2009 and CKD-EPI 2021 showed larger bias and lower P30 than EKFC 2021 and RLM. There were no meaningful differences in performance across eGFRcys equations. Findings were consistent across comorbid conditions, and eGFRcr-cys equations showed good performance in patients with liver disease, cancer and heart failure. Conclusions In conclusion, eGFRcr-cys equations performed best, with minimal variation among equations in this Swedish cohort. The lower performance of CKD-EPI eGFRcr equations compared with EKFC and RLM may reflect differences in population characteristics and mGFR methods. Implementing eGFRcr equations will require a trade-off between accuracy and uniformity across regions.

Funder

Swedish Research Council

Dutch Kidney Foundation

Netherlands Organisation for Scientific Research

Karolinska Institutet

Publisher

Oxford University Press (OUP)

Subject

Transplantation,Nephrology

Reference56 articles.

1. Uses of GFR and albuminuria level in acute and chronic kidney disease;Levey;N Engl J Med,2022

2. Measured and estimated glomerular filtration rate: current status and future directions;Levey;Nat Rev Nephrol,2020

3. KDIGO 2012 clinical practice guideline for the evaluation and management of chronic kidney disease;Kidney Disease: Improving Global Outcomes (KDIGO) CKD Work Group;Kidney Int Suppl,2013

4. New creatinine- and cystatin C-based equations to estimate GFR without race;Inker;N Engl J Med,2021

5. Development and validation of a modified full age spectrum creatinine-based equation to estimate glomerular filtration rate : a cross-sectional analysis of pooled data;Pottel;Ann Intern Med,2021

Cited by 3 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3